Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer
Nadia Boromand et al, 2018, J Cell Physiol CrossRef
Culture supernatants of cervical cancer cells induce an M2 phenotypic profile in THP-1 macrophages
Eliza Julia Pedraza-Brindis et al, 2016, Cellular Immunology CrossRef
Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis.
Paweł Łaniewski et al, 2019, Sci Rep CrossRef
Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes
Matthew L. Scott et al, 2018, Virology CrossRef
Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis.
Zulei Zhang et al, 2019, Cancer Biol Ther CrossRef
HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.
Fatemeh Moosavi et al, 2019, Crit Rev Clin Lab Sci CrossRef
KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells
Lu Dai et al, 2017, Oncotarget CrossRef
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence
Jianjiang Fu et al, 2021, Oncogene CrossRef
Sequential Release of Paclitaxel and Imatinib from Core–Shell Microparticles Prepared by Coaxial Electrospray for Vaginal Therapy of Cervical Cancer
Zhepeng Liu et al, 2021, IJMS CrossRef
CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
Elodie Coquan et al, 2021, BMC Cancer CrossRef
CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space
Jan Korbecki et al, 2022, IJMS CrossRef
Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations
Katalin Balázs et al, 2022, Cancers CrossRef
Place des thérapies innovantes dans la prise en charge des cancers du col de l’utérus
Diana Bello Roufai, 2023, Bulletin du Cancer CrossRef